Madiyalakan R, Yazawa S, Barlow J J, Matta K L
Cancer Lett. 1986 Feb;30(2):201-5. doi: 10.1016/0304-3835(86)90089-3.
Serum alpha(1----3)-L-fucosyltransferase activity was measured in 29 ovarian cancer patients with active disease, 26 ovarian cancer patients with no clinical evidence of disease and 23 healthy females. N-Acetyl-2'-O-methyl-lactosamine was used as the acceptor for the enzyme. The level of the enzyme activity was significantly (P less than 0.05) higher in the serum of patients with known tumor when compared to healthy controls and patients with no clinical evidence of disease.
对29例患有活动性疾病的卵巢癌患者、26例无疾病临床证据的卵巢癌患者以及23名健康女性的血清α(1----3)-L-岩藻糖基转移酶活性进行了测定。N-乙酰-2'-O-甲基乳糖胺用作该酶的受体。与健康对照组和无疾病临床证据的患者相比,已知患有肿瘤的患者血清中的酶活性水平显著更高(P<0.05)。